IP Library Granted Patent US 12,629,474
Granted Patent B2
US 12,629,474 · App. 18/006,213 · Granted May 19, 2026

Valve assembly for drug delivery device

Inventor: Christina Rabolli (Mahwah, NJ)
Assignee: Becton, Dickinson and Company
A61M5/2466A61M5/14248A61M5/31576A61M5/3232
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,629,474
App. No.
18/006,213
Granted
May 19, 2026
Kind
B2
Abstract

A valve assembly for a drug delivery device includes a valve housing, a cannula having a first end and a second end positioned opposite the first end, a valve boot connected to the valve housing and defining an interior space, a valve sleeve defining a cannula space, with the valve sleeve configured to move from a pre-use position where the first end of the cannula is received within the cannula space to a use position where the first end of the cannula extends outside of the valve sleeve and the cannula space, and a piercing member having a body with a piercing tip. The body of the piercing member has a first end and a second end positioned opposite the first end, with the piercing member engaged with the valve sleeve.

Claims (29)

1 . A valve assembly for a drug delivery device, the valve assembly comprising:

a valve housing having a first side and a second side positioned opposite from the first side;

a cannula having a first end and a second end positioned opposite the first end, the cannula defining a central passageway;

a valve boot connected to the valve housing and defining an interior space, the valve boot is configured to move from a pre-use position where the first end of the cannula is received within the interior space to a use position where the first end of the cannula extends outside of the valve boot and the interior space;

a valve sleeve defining a cannula space, the valve sleeve is configured to move from a pre-use position where the first end of the cannula is received within the cannula space to a use position where the first end of the cannula extends outside of the valve sleeve and the cannula space; and

a piercing member having a body with a piercing tip, the body of the piercing member having a first end and a second end positioned opposite the first end, the piercing member engaged with the valve sleeve, wherein the body of the piercing member defines a central passageway, the central passageway receiving a portion of the valve sleeve.

2 . The valve assembly of claim 1 , wherein the piercing member is entirely spaced from the valve boot.

3 . The valve assembly of claim 1 , wherein the second end of the body of the piercing member is engaged with the valve sleeve.

4 . The valve assembly of claim 3 , wherein the second end of the body of the piercing member is received by a recessed area defined by the valve sleeve.

5 . The valve assembly of claim 1 , wherein the valve sleeve comprises a first cylindrical portion having a convex tip, a second portion extending from the first portion, and a third frustoconical portion extending from the second portion.

6 . The valve assembly of claim 5 , wherein the second end of the body of the piercing member is received by a recessed area defined by the second portion of the valve sleeve.

7 . The valve assembly of claim 5 , wherein the first cylindrical portion of the valve sleeve is positioned between the first end and the second end of the body of the piercing member.

8 . The valve assembly of claim 5 , wherein the second portion of the valve sleeve comprises a frustoconical section and a cylindrical section.

9 . The valve assembly of claim 5 , wherein the third portion of the valve sleeve comprises at least one recessed portion configured to facilitate a collapse and deformation of the valve sleeve.

10 . The valve assembly of claim 1 , wherein the body of the piercing member is cylindrical.

11 . The valve assembly of claim 1 , wherein the valve sleeve comprises an elastomeric material.

12 . The valve assembly of claim 1 , wherein the valve boot comprises an elastomeric material.

13 . The valve assembly of claim 1 , wherein the piercing member comprises metal.

14 . A drug delivery device comprising:

a housing;

a cartridge received within the housing, the cartridge configured to receive a medicament;

a drive assembly received within the housing and configured to engage the cartridge and dispense medicament from the cartridge;

a needle actuator assembly received within the housing, the needle actuator assembly comprising a patient needle configured to pierce a patient's skin; and

a valve assembly, comprising:

a valve housing having a first side and a second side positioned opposite from the first side,

a cannula having a first end and a second end positioned opposite the first end, the cannula defining a central passageway,

a valve boot connected to the valve housing and defining an interior space, the valve boot is configured to move from a pre-use position where the first end of the cannula is received within the interior space to a use position where the first end of the cannula extends outside of the valve boot and the interior space,

a valve sleeve defining a cannula space, the valve sleeve is configured to move from a pre-use position where the first end of the cannula is received within the cannula space to a use position where the first end of the cannula extends outside of the valve sleeve and the cannula space, and

a piercing member having a body with a piercing tip, the body of the piercing member having a first end and a second end positioned opposite the first end, the piercing member engaged with the valve sleeve, wherein the body of the piercing member defines a central passageway, the central passageway receiving a portion of the valve sleeve.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 20, 2023
From: RABOLLI, CHRISTINA
To: BECTON, DICKINSON AND COMPANY
Reel/Frame 062435/0342 →
Continuity (2)
Provisional Application 63054850 · Jul 22, 2020
Related Publication 20230310747A1 · Oct 5, 2023
References Cited (16)
US 7140592B2 · Phillips · 2006 [cited by applicant]
US 10391245B2 · Cronenberg et al. · 2019 [cited by applicant]
US 10406280B2 · Cronenberg · 2019 [cited by applicant]
US 10583241B2 · Wu et al. · 2020 [cited by applicant]
US 11065388B2 · Cowe et al. · 2021 [cited by applicant]
US 11129936B2 · Gibson · 2021 [cited by examiner]
US 11484649B2 · Falkovich · 2022 [cited by examiner]
US 20170028132A1 · Cronenberg · 2017 [cited by examiner]
US 20170182307A1 · Halili et al. · 2017 [cited by applicant]
US 20170354788A1 · Quinn et al. · 2017 [cited by applicant]
CA 3020337A1 · 2017 [cited by applicant]
CN 1802183A · 2006 [cited by applicant]
CN 107980006A · 2018 [cited by applicant]
WO 2013155153A1 · 2013 [cited by applicant]
WO 2014179774A1 · 2014 [cited by applicant]
WO 2020243387A1 · 2020 [cited by applicant]